Favipiravir therapy for patients with covid-19 pneumonia: An observational study

• Main Authors: Supawadee Suppadungsuk, Thananya Wongsinin, Sirawat Srichatrapimuk, Suppachok Kirdlarp, Kulapong Jayanama, Kanin Thammavaranucupt, Dhanesh Pitidhammabhorn, Sithakom Phusanti, Nithita Nanthatanti, Somnuek Sungkanuparph
• Other Authors: Faculty of Medicine Ramathibodi Hospital, Mahidol University
• Format: Article
• Published: 2022
• Subjects: Medicine
• Online Access: https://repository.li.mahidol.ac.th/handle/123456789/78454
• Institution: Mahidol University

Pneumonia in patients with COVID-19 is sometimes severe and life-threatening, and currently there is no specific effective drug approved for COVID-19 treatment. Favipiravir is a pyrazine analog inhibiting RNA virus RNA dependent RNA polymerase with antiviral activity against SARS-CoV-2. An observati...